Yen-tervention risks remain in focus to start the new week
Towards the end of last week, USD/JPY offered up some interesting price moves. The currency pair fell in the run up to the US jobs report before some pushing and pulling in holiday-thin trading on Friday. But after settling near unchanged from just before the non-farm payrolls, we're now seeing the pair run up again from 161.40 to 161.90 levels.
As much as there are other factors driving dollar sentiment and the broader risk mood, intervention risks remain the most influential driver of price action for USD/JPY currently.
The drop on Thursday and Friday was arrested somewhere around 160.70 levels, before dip buyers stepped back in. The sudden drop on Thursday especially was notable as it saw price action fall back below the key hourly moving averages.
That put a more bearish near-term bias in place but is now being reversed again as dip buyers step in to retest the confluence of the 100 (red line) and 200-hour (blue line) moving averages at 161.84-92. A break above that region will see the near-term bias switch to being more bullish again.
After briefly breaching the 2024 highs last week, traders were more guarded in terms of positioning ahead of the US jobs report. But with that now out of the way, is the path clear for another run above the 162.00 level?
There is a good argument for that with the path of least resistance still leaning towards a weaker Japanese yen currency. The only question is, will Tokyo officials step in to try and slow down the bleeding?
The economic calendar this week will not have any major risk events as influential as the non-farm payrolls. As such, traders will be left to their own devices in dictating proceedings. And if they do take a firm run back towards the highs last week near 162.80, that could really invite Japan's ministry of finance to meddle considering that there is nothing else that could pressure traders into backing off.
It's all a psychological game at this stage.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
As AI controversies escalate, hedge funds buy tech stocks at the fastest pace in 15 months
Hedge funds have recorded net purchases of US TMT stocks on 10 out of the past 11 trading days, rebuilding tech long positions at the fastest pace in 15 months. However, an AI policy storm has struck at the "worst possible time"—calls by AI giants to slow down development have been rejected, and regulatory uncertainty has directly hit Asian tech stocks such as Softbank. As the tech sector's bullish run coincides with Super Central Bank Week, the sector now faces a severe test.
Apple Pre-sale Tracker: iPhone 18 Pro Series Shows Weak Overseas Demand Signals, Duo Review Positive but Hardware Lags Behind
According to a survey by Jefferies, after the launch of the iPhone 18 Pro, delivery wait times in the four major markets—the US, UK, Germany, and Japan—have shortened by 5 to 11 days compared to last year, with no wait time in the US. Given stable production capacity, this is a clear sign of weak demand. Although the China and Hong Kong markets have performed better against the trend, there are still suspicions of speculative stockpiling. The new foldable Duo has been praised for its software experience, but its $2,000 price tag comes with a 254-gram body and dual-camera setup, leaving its hardware lagging significantly behind Android competitors. Jefferies maintains an "underperform" rating, with a target price implying a 21% downside from the current level.
SUI holds $0.71 support as analysts cite key buy signal, eyes on possible recovery
UBS Health Benefit Survey: Elevance Health (ELV.US) Leads, U.S. Employers Prepare for Rising Medical Costs
In the annual survey by UBS for employee benefits management institutions, Elevance Health (ELV.US) emerged as the highest-rated US health insurance company.
Crypto prices
More
